| B-07 Hans Peter Grimm Learn-and-Confirm in Quantitative Systems Pharmacology: Evaluation of an Immunogenicity Platform Wednesday 11:15-11:35 |
| B-08 Rory Leisegang Immunogenicity dynamics and covariate effects after satralizumab administration predicted with a Hidden Markov Model Wednesday 11:55-12:15 |
| B-08 Alix Demaris Towards understanding anti-infliximab antibody development to predict Crohn’s disease patients' underlying immunogenicity status Wednesday 11:35-11:55 |
